An experimental GLP-1 pill has helped overweight adults with type 2 diabetes shed 10.5 per cent of body weight in a late-stage trial.
Eli Lilly confirmed the results on Tuesday after data from an earlier study of the drug in patients without diabetes sent company shares tumbling.